Compare Abbott Laboratories (ABT) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Monolithic Power Systems Inc — how do they compare? Abbott Laboratories trades at $95.58 (market cap $166.94B), while Monolithic Power Systems Inc trades at $1,321.2 (market cap $62.53B). The key difference: Abbott Laboratories is far larger — about 2.7× Monolithic Power Systems Inc's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | MPWR | |
|---|---|---|
Market Cap | $166.94B | $62.53B |
Sector | Health | Utilities |
52-Week High | $136.62 | $1.69K |
52-Week Low | $82.57 | $711.24 |
Enterprise Value | $193.69B | $61.19B |
Dividend Yield | 2.63% | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
MPWR trades at $1,346.13, up 4.5% in the past 24 hours, showing strong momentum. The stock exhibits bearish technical signals but benefits from consistent earnings beats and robust profitability, with a net margin of 22.98%. Recent news highlights growth in AI infrastructure and consumer electronics demand. Cash flow remains positive, and a $2.00 dividend is scheduled for July 2026.
Outlook is supported by analyst optimism (88% buy ratings) and a consensus price target of $1,760, though high valuation multiples and ongoing legal investigations pose risks. Revenue growth and AI-driven demand present opportunities, but investors should weigh elevated P/E of 96.36 against potential market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
